Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer
Clinical trial NCT07051785 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07051785
- Sponsor
- Liu Huang
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2027-07-06
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.